Agenus Newsroom

Agenus Analyst Ratings

BenzingaAug 14 21:29

B. Riley Adjusts Price Target on Agenus to $18 From $42, Maintains Buy Rating

MT NewswiresAug 14 19:59

B.Riley Financial Maintains Agenus(AGEN.US) With Buy Rating, Cuts Target Price to $18

Futu NewsAug 14 02:31

Agenus Hold Rating: Balancing Phase 2 Progress With Regulatory Challenges and Uncertainty

TipRanksAug 8 23:39

Jefferies Downgrades Agenus to Hold, Raises Price Target to $7

BenzingaJul 20 05:17

Agenus Downgraded at Baird After FDA Feedback on Cancer Drug

Seeking AlphaJul 19 21:12

HC Wainwright Downgrades Agenus to Neutral From Buy, Adjusts Price Target to $9 From $40

MT NewswiresJul 19 19:08

Hold Rating Justified for Agenus Amidst Regulatory Uncertainties and Mixed Clinical Results

TipRanksJul 19 16:29

HC Wainwright & Co. Downgrades Agenus to Neutral, Lowers Price Target to $9

BenzingaJul 19 00:39

Agenus Analyst Ratings

BenzingaJul 19 00:37

Agenus Analyst Ratings

BenzingaJun 29 01:32

HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $40 Price Target

BenzingaJun 29 01:32

Buy Rating Affirmed for Agenus Amid Promising Colorectal Cancer Study Results

TipRanksMay 25 02:00

Agenus Analyst Ratings

BenzingaMay 24 19:20

HC Wainwright & Co. Reiterates Buy on Agenus, Maintains $40 Price Target

BenzingaMay 24 19:20

Analysts Offer Insights on Healthcare Companies: Agenus (AGEN), Merus (MRUS) and Iovance Biotherapeutics (IOVA)

TipRanksMay 24 18:26

Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), Eledon Pharmaceuticals (ELDN) and Agenus (AGEN)

TipRanksMay 8 20:41

HC Wainwright & Co. : The Agenus (AGEN.US) rating was reaffirmed and adjusted from buy to buy, and the target price was $40.00.

Zhitong FinanceMay 8 02:11

Agenus Analyst Ratings

BenzingaMay 8 02:11

Analysts Offer Insights on Healthcare Companies: Biomea Fusion (BMEA), Repligen (RGEN) and Agenus (AGEN)

TipRanksMay 3 19:50